** Medical equipment maker Japan Lifeline Co Ltd 7575.T
jumps as much as 8.5 pct to 3,230 yen, highest since April 2
** CLSA hikes co's target price to 4,100 yen from 4,000 yen
** Says co's net profit to rise 21 pct in FY ending March
2019, driven by new products including drug-eluting stent
Orsiro, laser balloon HeartLight and the Perceval heart valve
** As of previous close, stock up 26.36 pct so far this year
** Among the analysts that cover Japan Lifeline, the current
average rating on the shares is "buy"; the breakdown of
recommendations is four "strong buy" or "buy", one "hold" and no
"sell" or "strong sell". The analyst mean price target is 3,706
yen
(Reuters
Messaging:ayai.tomisawa.thomsonreuters.com@reuters.net)